NeoChord Set To Start US Trial Of Artificial Chordae Tendinae System

NeoChord is now training 20 US centers in preparation for a US randomized clinical trial to support a PMA for its NeoChord DS1000 artificial chordae delivery system for minimally invasive mitral valve repair.

More from Archive

More from Medtech Insight